We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
125 hedge funds and large institutions have $770M invested in Sana Biotechnology in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
46% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 28
8% more funds holding
Funds holding: 116 → 125 (+9)
1.24% more ownership
Funds ownership: 66.22% → 67.45% (+1.2%)
5% less capital invested
Capital invested by funds: $808M → $770M (-$37.8M)
11% less call options, than puts
Call options by funds: $92K | Put options by funds: $103K
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
125
Holders Change
+9
Holders Change %
+7.76%
% of All Funds
2.15%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
41
Reduced
28
Closed
7
Calls
$92K
Puts
$103K
Net Calls
-$11K
Net Calls Change
-$221K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$8.08M |
| 2 |
Millennium Management
New York
|
+$5.75M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.68M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.4M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$5.31M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$14.8M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$5.14M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.91M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.89M |
| 5 |
Morgan Stanley
New York
|
-$1.67M |
